Quote this publication Share Print

LANTUS

-
Opinions on drugs - Posted on Feb 10 2014

Reason for request

Extension of indication

-


Clinical Benefit

Substantial

Substantial in type 1 diabetes in children aged 2 to 5 years.


Clinical Added Value

no clinical added value

LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes.